Mondor I, Ugolini S, Sattentau Q J
Centre d'Immunologie de Marseille-Luminy, Marseille, France.
J Virol. 1998 May;72(5):3623-34. doi: 10.1128/JVI.72.5.3623-3634.1998.
The binding of human immunodeficiency virus type 1 (HIV-1) (Hx10) virions to two different cell lines was analyzed by using a novel assay based on the detection, by anti-HLA-DR-specific antibodies, of HLA-DR+ virus binding to HLA-DR- cells. Virion attachment to the CD4+-T-cell line A3.01 was highly CD4 dependent in that it was potently inhibited by CD4 monoclonal antibodies (MAbs), and little virus binding to the CD4- sister A2.01 line was observed. By contrast, virion binding to HeLa cells expressing moderate or high levels of CD4 was equivalent to, or lower than, binding to wild-type CD4- HeLa cells. Moreover, several CD4 MAbs did not reduce, but enhanced, HIV-1 attachment to HeLa-CD4 cells. CD4 was required for infection of HeLa cells, however, demonstrating a postattachment role for this receptor. MAbs specific for the V2 and V3 loops and the CD4i epitope of gp120 strongly inhibited virion binding to HeLa-CD4 cells, whereas MAbs specific for the CD4bs and the 2G12 epitopes enhanced attachment. Despite this, all gp120- and gp41-specific MAbs tested neutralized infectivity on HeLa-CD4 cells. HIV-1 attachment to HeLa cells was only partially inhibited by MAbs specific for adhesion molecules present on the virus or target cells but was completely blocked by polyanions such as heparin, dextran sulfate, and pentosan sulfate. Treatment of HeLa-CD4 cells with heparinases completely eliminated HIV attachment and infection, strongly implicating cell surface heparans in the attachment process. CD4 dependence for HIV-1 attachment to target cells is thus highly cell line specific and may be replaced by other ligand-receptor interactions.
通过一种基于抗HLA - DR特异性抗体检测HLA - DR +病毒与HLA - DR -细胞结合的新型检测方法,分析了1型人类免疫缺陷病毒(HIV - 1)(Hx10)病毒粒子与两种不同细胞系的结合情况。病毒粒子与CD4 + T细胞系A3.01的附着高度依赖于CD4,因为它被CD4单克隆抗体(MAbs)强烈抑制,并且几乎未观察到病毒与CD4 -姐妹细胞系A2.01的结合。相比之下,病毒粒子与表达中度或高水平CD4的HeLa细胞的结合等同于或低于与野生型CD4 - HeLa细胞的结合。此外,几种CD4单克隆抗体并未降低,反而增强了HIV - 1与HeLa - CD4细胞的附着。然而,HeLa细胞的感染需要CD4,这表明该受体在附着后发挥作用。针对gp120的V2和V3环以及CD4i表位的单克隆抗体强烈抑制病毒粒子与HeLa - CD4细胞的结合,而针对CD4bs和2G12表位的单克隆抗体则增强了附着。尽管如此,所有测试的gp120和gp41特异性单克隆抗体均中和了HeLa - CD4细胞上的感染性。HIV - 1与HeLa细胞的附着仅被针对病毒或靶细胞上存在的粘附分子的单克隆抗体部分抑制,但被诸如肝素、硫酸葡聚糖和硫酸戊聚糖等多阴离子完全阻断。用肝素酶处理HeLa - CD4细胞完全消除了HIV的附着和感染,强烈表明细胞表面硫酸乙酰肝素参与了附着过程。因此,HIV - 1附着于靶细胞对CD4的依赖性具有高度细胞系特异性,并且可能被其他配体 - 受体相互作用所取代。